Literature DB >> 11083799

Identification and immunogenicity of group A Streptococcus culture supernatant proteins.

B Lei1, S Mackie, S Lukomski, J M Musser.   

Abstract

Extracellular proteins made by group A Streptococcus (GAS) play critical roles in the pathogenesis of human infections caused by this bacterium. Although many extracellular GAS proteins have been identified and characterized, there has been no systematic analysis of culture supernatant proteins. Proteins present in the culture supernatant of strains of serotype M1 (MGAS 5005) and M3 (MGAS 315) mutants lacking production of the major extracellular cysteine protease were separated by two-dimensional gel electrophoresis and identified by amino-terminal amino acid sequencing and interrogation of available databases, including a serotype M1 genome sequence. In the aggregate, amino-terminal amino acid sequence data for 66 protein spots were generated, 53 unique sequences were obtained, and 44 distinct proteins were identified. Sixteen of the 44 proteins had apparent secretion signal sequences and 27 proteins did not. Eight of the 16 proteins with apparent secretion signal sequences have not been previously described for GAS. Antibodies against most of the apparently secreted proteins were present in sera from mice infected subcutaneously with MGAS 5005 or MGAS 315. Humans with documented GAS infections (pharyngitis, acute rheumatic fever, and severe invasive disease) also had serum antibodies reacting with many of the apparently secreted proteins, indicating that they were synthesized in the course of GAS-human interaction. The genes encoding four of the eight previously undescribed and apparently secreted culture supernatant proteins were cloned, and the proteins were overexpressed in Escherichia coli. Western blot analysis with these recombinant proteins and sera from GAS-infected mice and humans confirmed the immunogenicity of these proteins. Taken together, the data provide new information about the molecular aspects of GAS-host interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083799      PMCID: PMC97784          DOI: 10.1128/IAI.68.12.6807-6818.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.

Authors:  N P Hoe; K Nakashima; S Lukomski; D Grigsby; M Liu; P Kordari; S J Dou; X Pan; J Vuopio-Varkila; S Salmelinna; A McGeer; D E Low; B Schwartz; A Schuchat; S Naidich; D De Lorenzo; Y X Fu; J M Musser
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

3.  Serum inhibition of streptococcal diphosphopyridine nucleotidase in uncomplicated streptococcal pharyngitis and in rheumatic fever.

Authors:  G C BERNHARD; G H STOLLERMAN
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

4.  Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis.

Authors:  P R Jungblut; G Grabher; G Stöffler
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

5.  Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.

Authors:  S Lukomski; C A Montgomery; J Rurangirwa; R S Geske; J P Barrish; G J Adams; J M Musser
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Effects of environmental pH on membrane proteins in Borrelia burgdorferi.

Authors:  J A Carroll; C F Garon; T G Schwan
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens.

Authors:  P R Jungblut; U E Schaible; H J Mollenkopf; U Zimny-Arndt; B Raupach; J Mattow; P Halada; S Lamer; K Hagens; S H Kaufmann
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

8.  A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3.

Authors:  K E Stockbauer; L Magoun; M Liu; E H Burns; S Gubba; S Renish; X Pan; S C Bodary; E Baker; J Coburn; J M Leong; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

9.  Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains.

Authors:  N Hoe; K Nakashima; D Grigsby; X Pan; S J Dou; S Naidich; M Garcia; E Kahn; D Bergmire-Sweat; J M Musser
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  Neutralizing antibodies to streptococcal diphosphopyridine nucleotidase in the serum of experimental animals and human beings.

Authors:  A KELLNER; E B FREEMAN; A S CARLSON
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

View more
  69 in total

1.  Alkaline phosphatase reporter transposon for identification of genes encoding secreted proteins in gram-positive microorganisms.

Authors:  Carmela M Gibson; Michael G Caparon
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

2.  Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.

Authors:  Srivishnupriya Anbalagan; Alexander Dmitriev; W Michael McShan; Paul M Dunman; Michael S Chaussee
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

Review 3.  The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Authors:  Alexander V Dmitriev; Michael S Chaussee
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

Review 4.  Common Non-classically Secreted Bacterial Proteins with Experimental Evidence.

Authors:  Guangqiang Wang; Yongjun Xia; Xin Song; Lianzhong Ai
Journal:  Curr Microbiol       Date:  2015-10-01       Impact factor: 2.188

5.  Identification of group A Streptococcus antigenic determinants upregulated in vivo.

Authors:  Kowthar Y Salim; Dennis G Cvitkovitch; Peter Chang; Darrin J Bast; Martin Handfield; Jeffrey D Hillman; Joyce C S de Azavedo
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 6.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Functional analysis of glucan binding protein B from Streptococcus mutans.

Authors:  Renata O Mattos-Graner; Kristen A Porter; Daniel J Smith; Yumiko Hosogi; Margaret J Duncan
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

8.  Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.

Authors:  Ronan K Carroll; Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Muthiah Kumaraswami; Stephen B Beres; Patrick R Shea; Anthony R Flores; James M Musser
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

9.  Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Authors:  Stephen B Beres; Gail L Sylva; Kent D Barbian; Benfang Lei; Jessica S Hoff; Nicole D Mammarella; Meng-Yao Liu; James C Smoot; Stephen F Porcella; Larye D Parkins; David S Campbell; Todd M Smith; John K McCormick; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.

Authors:  James A Tsatsaronis; Andrew Hollands; Jason N Cole; Peter G Maamary; Christine M Gillen; Nouri L Ben Zakour; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker; Martina L Sanderson-Smith
Journal:  FASEB J       Date:  2013-03-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.